These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Rhabdomyosarcoma AND MYC, c-Myc, 4609, ENSG00000136997
88 results:

  • 1. The transcriptional co-repressor Runx1t1 is essential for mycN-driven neuroblastoma tumorigenesis.
    Murray JE; Valli E; Milazzo G; Mayoh C; Gifford AJ; Fletcher JI; Xue C; Jayatilleke N; Salehzadeh F; Gamble LD; Rouaen JRC; Carter DR; Forgham H; Sekyere EO; Keating J; Eden G; Allan S; Alfred S; Kusuma FK; Clark A; Webber H; Russell AJ; de Weck A; Kile BT; Santulli M; De Rosa P; Fleuren EDG; Gao W; Wilkinson-White L; Low JKK; Mackay JP; Marshall GM; Hilton DJ; Giorgi FM; Koster J; Perini G; Haber M; Norris MD
    Nat Commun; 2024 Jul; 15(1):5585. PubMed ID: 38992040
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.
    Walker RL; Hornicek FJ; Duan Z
    Biochem Pharmacol; 2024 Aug; 226():116342. PubMed ID: 38848777
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Temporal Proteomic and Phosphoproteomic Analysis of EV-A71-Infected Human Cells.
    Zhao Y; Li L; Wang X; He S; Shi W; Chen S
    J Proteome Res; 2022 Oct; 21(10):2367-2384. PubMed ID: 36106392
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma.
    Di Rocco A; Camero S; Benedetti A; Lozanoska-Ochser B; Megiorni F; Marchese C; Stramucci L; Ciccarelli C; Bouché M; Bossi G; Marampon F; Zani BM
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35801577
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in rhabdomyosarcoma Treatment.
    Marchesi I; Fais M; Fiorentino FP; Bordoni V; Sanna L; Zoroddu S; Bagella L
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408939
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional impact and targetability of
    Choo F; Odintsov I; Nusser K; Nicholson KS; Davis L; Corless CL; Stork L; Somwar R; Ladanyi M; Davis JL; Davare MA
    Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 35012940
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fusion of the Paired Box 3 (
    Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 rhabdomyosarcoma Cells.
    Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC).
    Kurmasheva RT; Erickson SW; Han R; Teicher BA; Smith MA; Roth M; Gorlick R; Houghton PJ
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29304. PubMed ID: 34453478
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
    Huot M; Caron M; Richer C; Djibo R; Najmanovich R; St-Onge P; Sinnett D; Raynal NJM
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):845-856. PubMed ID: 34331108
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
    Rossetti A; Petragnano F; Milazzo L; Vulcano F; Macioce G; Codenotti S; Cassandri M; Pomella S; Cicchetti F; Fasciani I; Antinozzi C; Di Luigi L; Festuccia C; De Felice F; Vergine M; Fanzani A; Rota R; Maggio R; Polimeni A; Tombolini V; Gravina GL; Marampon F
    Int J Radiat Biol; 2021; 97(7):943-957. PubMed ID: 33979259
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cells.
    Laszig S; Boedicker C; Weiser T; Knapp S; Fulda S
    Cancer Lett; 2020 Aug; 486():46-57. PubMed ID: 32445837
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.
    Boedicker C; Hussong M; Grimm C; Dolgikh N; Meister MT; Enßle JC; Wanior M; Knapp S; Schweiger MR; Fulda S
    Oncogene; 2020 May; 39(19):3837-3852. PubMed ID: 32161312
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Establishment of Infectious Clone and Single Round Infectious Particles for Coxsackievirus A10.
    Wang M; Yan J; Zhu L; Wang M; Liu L; Yu R; Chen M; Xun J; Zhang Y; Yi Z; Zhang S
    Virol Sin; 2020 Aug; 35(4):426-435. PubMed ID: 32144688
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines.
    Marampon F; Di Nisio V; Pietrantoni I; Petragnano F; Fasciani I; Scicchitano BM; Ciccarelli C; Gravina GL; Festuccia C; Del Fattore A; Tombolini M; De Felice F; Musio D; Cecconi S; Tini P; Maddalo M; Codenotti S; Fanzani A; Polimeni A; Maggio R; Tombolini V
    Cancer Lett; 2019 Oct; 461():90-101. PubMed ID: 31325529
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.
    Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S
    Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.
    Kleinsimon S; Longmuss E; Rolff J; Jäger S; Eggert A; Delebinski C; Seifert G
    Sci Rep; 2018 Apr; 8(1):5750. PubMed ID: 29636527
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells.
    Zhou Z; Ai H; Li K; Yao X; Zhu W; Liu L; Yu C; Song Z; Bao Y; Huang Y; Wu Y; Zheng L; Sun Y; Wang G; Ma K; Sun L; Li Y
    Sci Rep; 2018 Jan; 8(1):1479. PubMed ID: 29367618
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.